WASHINGTON (Legal Newsline) – Daiichi Sankyo, Inc., a pharmaceutical company, has agreed to pay federal and state Medicaid programs more than $39 million over allegations that it used kickbacks to entice physicians into prescribing its medications, the U.S. Department of Justice said on Friday.
The settlement is the result of a whistleblower lawsuit filed by Kathy Fragoules, a former Daiichi employee who alleged the New Jersey-based firm provided entertainment such as dinners and paid speaking engagements to doctors in exchange for their prescribing patients the company’s drugs. The medications included Azor, Tribenzor, Welchol and Benicar.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.